According to ALX Oncology's latest financial reports the company's current EPS (TTM) is -$3.20. In 2022 the company made an earnings per share (EPS) of -$3.03 a decrease over its 2021 EPS that were of -$2.06.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.20 | 5.61% |
2022 | -$3.03 | 47.09% |
2021 | -$2.06 | 39.49% |
2020 | -$1.48 | 39.3% |
2019 | -$1.06 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -31.88% | ๐บ๐ธ USA |